DNA rearrangement activity during retinoic acid-induced neural differentiation of P19 mouse embryonal carcinoma cells.
Because of the many superficial similarities between the immune system and the central nervous system, it has long been speculated that somatic DNA recombination is, like the immune system, involved in brain development and function. To examine whether or not the V(D)J recombination signals of the immune system work in an in vitro neural differentiation model, the P19 mouse embryonal carcinoma cell line was transfected with a reporter gene that is designed, when rearranged, to express bacterial beta-galactosidase, which was previously reported to exhibit somatic DNA recombination in the transgenic mouse brain. The cloned cells were then induced into neural cells by retinoic acid treatment. This neural induction treatment resulted in the cloning of a P19 cell line that showed a high incidence of beta-galactosidase-positive cells. Most of these beta-galactosidase-positive cells were immunocytochemically identified as either neurons, neuroepithelial cells, or astrocytes. The 5'-end sequences of the beta-galactosidase transcripts expressed in the induced cells were analyzed, and sequences were found that seemed to reflect DNA rearrangement through re-integration of the reporter gene into the host genome. However, the V(D)J recombination signals did not work in the in vitro model. These results suggested that DNA rearrangement activity though integration increased during neural differentiation of P19 cells.
Kawabata
Masahiro
M
Department of Pharmacology, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558, Japan. mbat@md.okayama-u.ac.jp
Kawabata
Teruyuki
T
Saeki
Kiyomi
K
D000818:Animals; D001483:Base Sequence; D002454:Cell Differentiation / Q000502:physiology*; D045744:Cell Line, Tumor; D054278:Embryonal Carcinoma Stem Cells; D015321:Gene Rearrangement; D017930:Genes, Reporter; D051379:Mice; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D014411:Neoplastic Stem Cells / Q000166:cytology / Q000502:physiology*; D009474:Neurons / Q000166:cytology* / Q000187:drug effects* / Q000502:physiology; D014212:Tretinoin / Q000494:pharmacology*; D001616:beta-Galactosidase / Q000235:genetics / Q000378:metabolism
D014212:Tretinoin; D001616:beta-Galactosidase